M. tuberculosis genes required for pulmonary survival revealed by TraCS
TraCS 揭示肺存活所需的结核分枝杆菌基因
基本信息
- 批准号:8386090
- 负责人:
- 金额:$ 7.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AerosolsAllelesAntibioticsAntimycobacterial AgentsAntitubercular AgentsBacillus (bacterium)BacteriaBacterial DNABase SequenceBiological ModelsCaviaCessation of lifeComplementCoupledDeletion MutationDetectionDevelopmentDiseaseDoseDrug Resistant TuberculosisEnvironmentEpidemicExtreme drug resistant tuberculosisFutureGenesGeneticGenomeGoalsGrantGranulomaGrowthHIVHealthcareHumanHypoxiaIndividualInfectionInterventionLibrariesLightLungMaintenanceMethodologyModelingMusMutationMutation DetectionMycobacterium tuberculosisNecrosisOrganismOutcomeOutcome StudyPathogenesisPathway interactionsPharmaceutical PreparationsPhenotypePhysiologyPlaguePopulationPublic HealthResearchResearch Project GrantsResolutionScreening procedureSequence AnalysisTherapeuticTherapeutic InterventionTimeTuberculosisTuberculosis VaccinesVaccinesValidationWorkarmattenuationbasecohortdesigndrug developmentenzyme pathwaygene discoveryhuman diseaseimprovedin vivoin vivo Modelkillingsmouse modelmutantmycobacterialnovelpathogenprogramsresistant straintherapeutic developmentvaccine development
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis (Mtb) is one of the world's leading public health concerns, responsible for the deaths of more than 2 million people annually. The concurrent HIV epidemic coupled with the emergence of extensively drug resistant strains of Mtb have greatly amplified the impact of M. tuberculosis infection and created a global healthcare crisis. One of the problems facing those tasked with treating tuberculosis is that even infections caused by drug susceptible Mtb strains require long-term treatment in part because the anti-mycobacterial agents used currently are inefficient at killing host adapted bacteria. The primary objective of this work is to identify Mtb genes essential for adaptation to survival in the lung particularly those not identified in earlier screening approaches. The premise is that the more known about the physiology of the organism during infection, the greater is the opportunity to design successful therapeutic interventions which target in vivo essential bacterial enzymes and pathways. This work employs a whole genome screen of an Mtb transposon mutant library administered via aerosol to guinea pigs. The guinea pig host reproduces many aspects of human tuberculosis including the necrotic, hypoxic granuloma not found in all model systems, for example the mouse. The proposal has two AIMS. AIM1 is to apply Transposon Capture and Sequencing or TraCS analysis to existing guinea pig infection derived libraries. TraCs is a robust and highly sensitive deep sequencing based methodology, which allows the detection of mutations in Mtb genes which render the bacilli incapable of survival in the pulmonary environment. The second AIM is a confirmatory analysis of the screen wherein individual deletion alleles will be constructed in two genes identified in the original screen. The in vivo phenotype of the deletion mutants will be examined in the low dose aerosol guinea pig and murine tuberculosis infection models, and results will be compared to those observed with infection of wild type and complemented mutant strains. The inclusion of a murine infection cohort allows interspecies comparison and validation of the potential exclusivity of the particular
gene for maintenance of disease in the human-like pulmonary environment modeled by the guinea pig. Ultimately this work will contribute to the development of therapeutics which target pathways essential for bacilli survival in the host environment.
PUBLIC HEALTH RELEVANCE: Tuberculosis, a disease caused by the bacterium Mycobacterium tuberculosis, has plagued mankind since the time of the pharaohs and is currently one of the most significant public health threats facing the world's population. This research is implemented to shed light on the genetic mechanisms used by the bacterium to survive in its host. An anticipated long-term outcome of this work is the design of improved therapeutics (antibiotics and vaccines) to disable the bacterial pathways identified as being essential to bacterial survival and disease development.
描述(由申请人提供): 由结核分枝杆菌(Mtb)感染引起的结核病(TB)是世界上主要的公共卫生问题之一,每年造成超过200万人死亡。同时发生的HIV流行加上广泛耐药的结核分枝杆菌菌株的出现,极大地扩大了结核分枝杆菌的影响。结核病感染,造成全球医疗危机。那些负责治疗结核病的人面临的问题之一是,即使是由药物敏感的Mtb菌株引起的感染也需要长期治疗,部分原因是目前使用的抗分枝杆菌剂在杀死宿主适应性细菌方面效率低下。这项工作的主要目的是确定结核分枝杆菌基因的适应生存在肺,特别是那些没有确定在早期的筛选方法。前提是对感染期间生物体的生理学了解得越多,设计靶向体内必需细菌酶和途径的成功治疗干预的机会就越大。这项工作采用通过气溶胶对豚鼠进行Mtb转座子突变库的全基因组筛选。豚鼠宿主复制人结核病的许多方面,包括在所有模型系统(例如小鼠)中未发现的坏死性缺氧肉芽肿。该提案有两个目标。AIM 1将转座子捕获和测序或TraCS分析应用于现有豚鼠感染源文库。TraCs是一种稳健且高度灵敏的基于深度测序的方法,其允许检测Mtb基因中的突变,所述突变使得杆菌不能在肺环境中存活。第二个AIM是筛选的验证性分析,其中将在原始筛选中鉴定的两个基因中构建单个缺失等位基因。将在低剂量气溶胶豚鼠和小鼠结核病感染模型中检查缺失突变体的体内表型,并将结果与野生型和补充突变菌株感染时观察到的结果进行比较。包括鼠感染队列允许种间比较和验证特定感染的潜在排他性。
在豚鼠模拟的类人肺环境中维持疾病的基因。最终,这项工作将有助于开发针对宿主环境中杆菌生存所必需的途径的治疗方法。
公共卫生相关性:结核病是一种由结核分枝杆菌引起的疾病,自法老时代以来一直困扰着人类,目前是世界人口面临的最严重的公共卫生威胁之一。这项研究的实施是为了阐明细菌在其宿主中生存所使用的遗传机制。这项工作的一个预期的长期成果是设计改进的治疗方法(抗生素和疫苗),以禁用被确定为对细菌生存和疾病发展至关重要的细菌途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY HONDALUS其他文献
MARY HONDALUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY HONDALUS', 18)}}的其他基金
M. tuberculosis genes required for pulmonary survival revealed by TraCS
TraCS 揭示肺存活所需的结核分枝杆菌基因
- 批准号:
8463982 - 财政年份:2012
- 资助金额:
$ 7.43万 - 项目类别:
Virulence of the Opportunistic Pathogen Rhodococcis Equi
机会性病原体马红球菌的毒力
- 批准号:
7576142 - 财政年份:2006
- 资助金额:
$ 7.43万 - 项目类别:
Virulence of the Opportunistic Pathogen Rhodococcis Equi
机会性病原体马红球菌的毒力
- 批准号:
7758845 - 财政年份:2006
- 资助金额:
$ 7.43万 - 项目类别:
Virulence of the opportunistic pathogen Rhodococcus equi
机会性病原体马红球菌的毒力
- 批准号:
7174191 - 财政年份:2006
- 资助金额:
$ 7.43万 - 项目类别:
Virulence of the Opportunistic Pathogen Rhodococcis Equi
机会性病原体马红球菌的毒力
- 批准号:
7064408 - 财政年份:2006
- 资助金额:
$ 7.43万 - 项目类别:
Virulence of the Opportunistic Pathogen Rhodococcis Equi
机会性病原体马红球菌的毒力
- 批准号:
7343180 - 财政年份:2006
- 资助金额:
$ 7.43万 - 项目类别:
MACROPHAGE RECONGNITION AND PHAGOCYTOSIS OF RHODOCOCCUS
红球菌的巨噬细胞识别和吞噬作用
- 批准号:
3085401 - 财政年份:1991
- 资助金额:
$ 7.43万 - 项目类别:
MACROPHAGE RECOGNITION AND PHAGOCYTOSIS OF RHODOCOCCUS
红球菌的巨噬细胞识别和吞噬作用
- 批准号:
3085403 - 财政年份:1991
- 资助金额:
$ 7.43万 - 项目类别:
MACROPHAGE RECOGNITION AND PHAGOCYTOSIS OF RHODOCOCCUS
红球菌的巨噬细胞识别和吞噬作用
- 批准号:
2057019 - 财政年份:1991
- 资助金额:
$ 7.43万 - 项目类别:
MACROPHAGE RECONGNITION AND PHAGOCYTOSIS OF RHODOCOCCUS
红球菌的巨噬细胞识别和吞噬作用
- 批准号:
3085402 - 财政年份:1991
- 资助金额:
$ 7.43万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:














{{item.name}}会员




